Vasostrict
These highlights do not include all the information needed to use VASOSTRICT safely and effectively. See full prescribing information for VASOSTRICT . Vasostrict (vasopressin injection) for intravenous use Initial U.S. Approval: 2014
Approved
Approval ID
6672a5c9-bcfd-d7fc-e053-2991aa0aef88
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jun 1, 2023
Manufacturers
FDA
Medical Purchasin Solutions, LLC
DUNS: 601458529
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Vasopressin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code71872-7014
Application NumberNDA204485
Product Classification
M
Marketing Category
C73594
G
Generic Name
Vasopressin
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJune 1, 2023
FDA Product Classification
INGREDIENTS (3)
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM ACETATEInactive
Code: 4550K0SC9B
Classification: IACT
VASOPRESSIN, UNSPECIFIEDActive
Quantity: 20 [USP'U] in 1 mL
Code: Y87Y826H08
Classification: ACTIB